结构:CC(C)CC1NC(=O)C(NC(=O)c2ncccc2O)C(C)OC(=O)C(c2ccccc2)N(C)C(=O)C(C)NC(=O)C(C(C)C(C)C)N(C)C(=O)CN(C)C(=O)C2CC(O)CN2C1=O
HCID417256

3-Hydroxy-N-(24-Hydroxy-7,11,13,17,20-Pentamethyl-16-(3-Methylbutan-2-Yl)-3-(2-Methylpropyl)-2,5,9,12,15,18,21-Heptaoxo-10-Phenyl-8-Oxa-1,4,11,14,17,20-Hexazabicyclo(20.3.0)Pentacosan-6-Yl)Pyridine-2-Carboxamide

3-hydroxy-N-[24-hydroxy-7,11,13,17,20-pentamethyl-16-(3-methylbutan-2-yl)-3-(2-methylpropyl)-2,5,9,12,15,18,21-heptaoxo-10-phenyl-8-oxa-1,4,11,14,17,20-hexazabicyclo[20.3.0]pentacosan-6-yl]pyridine-2-carboxamide

C44H62N8O11879 g/molCAS 102646-56-0

IDENTITY

结构与身份

标准 SMILES
CC(C)CC1NC(=O)C(NC(=O)c2ncccc2O)C(C)OC(=O)C(c2ccccc2)N(C)C(=O)C(C)NC(=O)C(C(C)C(C)C)N(C)C(=O)CN(C)C(=O)C2CC(O)CN2C1=O
InChIKey
SATIISJKSAELDC-UHFFFAOYSA-N
分子式
C44H62N8O11
平均分子量
879 g/mol
单同位素质量
878.45380482

COMPUTED

结构计算性质

已同步
XLogP
3.2
极性表面积
248 Ų
氢键供体
5
氢键受体
12
可旋转键
7
重原子
63
形式电荷
0
复杂度
1,670

ALIASES

名称与别名

23
3-hydroxy-N-[24-hydroxy-7,11,13,17,20-pentamethyl-16-(3-methylbutan-2-yl)-3-(2-methylpropyl)-2,5,9,12,15,18,21-heptaoxo-10-phenyl-8-oxa-1,4,11,14,17,20-hexazabicyclo[20.3.0]pentacosan-6-yl]pyridine-2-carboxamide3-Hydroxy-N-(24-Hydroxy-7,11,13,17,20-Pentamethyl-16-(3-Methylbutan-2-Yl)-3-(2-Methylpropyl)-2,5,9,12,15,18,21-Heptaoxo-10-Phenyl-8-Oxa-1,4,11,14,17,20-Hexazabicyclo(20.3.0)Pentacosan-6-Yl)Pyridine-2-CarboxamideRefChem:1067982Antibiotic 6613ENTAMYCINAntibioticum 6613NSC88468Antibioticum 6613 [German]102646-56-0Neoviridogrisein IVAntibiotic K-179Antibiotic F-1370ASCHEMBL4088801CHEMBL1993563SCHEMBL29403733AEC46721NSC-88468BS-1380Glycine, N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-leucyl-4-allo-hydroxy-D-prolyl-N-methylglycyl-N,3,4-trimethyl-L-norvalyl-L-alanyl-N-methyl-L-2-phenyl-, .upsilon.-lactoneGlycine, N-[N-[N-[N-[4-allo-hydroxy-1-[N-[N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl]-D-leucyl]-D-prolyl]-N-methylglycyl]-N,3-dimethyl-L-leucyl]-L-alanyl]-N-methyl-L-2-phenyl-, .upsilon.-lactone

REACTIONS

参与反应

1